NanoString

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

Contact Details

NanoString Technologies, Inc.
530 Fairview Ave N #2000
Seattle, WA 98109
(888) 358-6266

Company website

Content by NanoString:

Diagnostics Oncology

Resolving the Pathologist's Dilemma

02/25/2018 | Sponsored by NanoString

Current assays present a choice between spatial, information, and plex. But compromise may not be necessary

Digital Spatial Profiling (DSP): Quantitate and Profile 30+ Proteins With Morphological Context

01/15/2018 | Contributed by NanoString

Webinars on Demand

Diagnostics Biochemistry and molecular biology

Digital Spatial Profiling for Biomarker Discovery – 18,000-plex

09/21/2022 | Sponsored by NanoString

This webinar will discuss these approaches to spatial analysis and include an example of both protein and mRNA assessment of tissue using DSP as a biomarker discovery tool.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Pathologist magazine